Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 4/2017

06.02.2017 | Gynecologic Oncology

Obesity risk awareness in women with endometrial cancer

verfasst von: Elizabeth V. Connor, Christina A. Raker, Melissa A. Clark, Ashley R. Stuckey

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 4/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To assess whether women with endometrial cancer could accurately classify their weight and identify the association between obesity and risk of endometrial, breast, and colon cancers.

Methods

This was an IRB-approved (Project No. 14-0075), survey-based cross-sectional study of women ages 18–80 years with a diagnosis of endometrial cancer. Patients were at least 6 months from hysterectomy and 3 months from chemotherapy or radiation. Statistical analysis was completed using Fisher’s exact test, T test, ANOVA, Wilcoxon rank-sum test, or Kruskal–Wallis test. P values were two-tailed with P < 0.05 considered statistically significant.

Results

140 women met inclusion criteria, and 133 questionnaires (95.0%) were completed. Mean age was 63.2 years (range 35–80), and mean BMI was 33.4 kg/m2 (range 17.6–72.2). Patients were primarily Caucasian (88.7%) and reported education beyond high school (67.8%). Among women with BMI 30.0–34.99 kg/m2, 12.9% perceived themselves as obese, compared to 32.0% of women with BMI 35.0–39.99 kg/m2, and 72.7% of women with BMI >40.0 kg/m2. Ability to correctly classify weight correlated significantly with education level (P = 0.02). Less than half of women identified obesity as a risk factor for breast (49.6%), colon (48.1%), and endometrial cancer (44.4%). 77% of all patients had discussed weight with their primary care doctor, and 38% had discussed weight with their oncologist (P < 0.001).

Conclusions

The majority of obese women with endometrial cancer surveyed were unable to accurately classify their weight. Given the inconsistency between patient weight and perception of cancer risk, this represents an opportunity for gynecologic oncologists to educate their patients about weight control.
Literatur
2.
Zurück zum Zitat Calle EE, Rodriguez C, Walker-Thurmond K et al (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med 348:1625–1638CrossRefPubMed Calle EE, Rodriguez C, Walker-Thurmond K et al (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med 348:1625–1638CrossRefPubMed
3.
Zurück zum Zitat Crosbie EJ, Zwahlen M, Kitchener HC (2010) Body mass index, hormone replacement therapy, and endometrial cancer risk: a meta-analysis. Cancer Epidemiol Biomark Prev 19:3119–3130CrossRef Crosbie EJ, Zwahlen M, Kitchener HC (2010) Body mass index, hormone replacement therapy, and endometrial cancer risk: a meta-analysis. Cancer Epidemiol Biomark Prev 19:3119–3130CrossRef
4.
Zurück zum Zitat Jenabi E, Poorolaial J (2015) The effect of body mass index on endometrial cancer: a meta-analysis. Public Health 129(7):872–880CrossRefPubMed Jenabi E, Poorolaial J (2015) The effect of body mass index on endometrial cancer: a meta-analysis. Public Health 129(7):872–880CrossRefPubMed
5.
Zurück zum Zitat MacKintosh ML, Crosbie EJ (2013) Obesity-driven endometrial cancer: is weight loss the answer? BJOG 120:791–794CrossRefPubMed MacKintosh ML, Crosbie EJ (2013) Obesity-driven endometrial cancer: is weight loss the answer? BJOG 120:791–794CrossRefPubMed
6.
Zurück zum Zitat Renehan A, Tyson M, Egger M et al (2008) Body mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371:569–578CrossRefPubMed Renehan A, Tyson M, Egger M et al (2008) Body mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371:569–578CrossRefPubMed
7.
8.
Zurück zum Zitat Koutoukidis DA, Knobf MT, Lancely A (2015) Obesity, diet, physical activity, and health-related quality of life in endometrial cancer survivors. Nutr Rev 73(6):399–408CrossRefPubMedPubMedCentral Koutoukidis DA, Knobf MT, Lancely A (2015) Obesity, diet, physical activity, and health-related quality of life in endometrial cancer survivors. Nutr Rev 73(6):399–408CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Smits A, Lopes A, Das N et al (2014) The impact of BMI on quality of life in obese endometrial cancer survivors: does size matter? Gynecol Oncol 132(1):137–141CrossRefPubMed Smits A, Lopes A, Das N et al (2014) The impact of BMI on quality of life in obese endometrial cancer survivors: does size matter? Gynecol Oncol 132(1):137–141CrossRefPubMed
10.
Zurück zum Zitat Arem H, Irqwin ML (2013) Obesity and endometrial cancer survival: a systematic review. Int J Obes (Lond) 37(5):634–639CrossRef Arem H, Irqwin ML (2013) Obesity and endometrial cancer survival: a systematic review. Int J Obes (Lond) 37(5):634–639CrossRef
11.
Zurück zum Zitat Gunderson CC, Java J, Moore KN et al (2014) The impact of obesity on surgical staging, complications, and survival with uterine cancer: a Gynecologic Oncology Group LAP2 ancillary data study. Gynecol Oncol 133(1):23–27CrossRefPubMed Gunderson CC, Java J, Moore KN et al (2014) The impact of obesity on surgical staging, complications, and survival with uterine cancer: a Gynecologic Oncology Group LAP2 ancillary data study. Gynecol Oncol 133(1):23–27CrossRefPubMed
12.
Zurück zum Zitat Ward KK, Shah NR, Saenz CC et al (2012) Cardiovascular disease is the leading cause of death among endometrial cancer patients. Gynecol Oncol 126(2):176–179CrossRefPubMed Ward KK, Shah NR, Saenz CC et al (2012) Cardiovascular disease is the leading cause of death among endometrial cancer patients. Gynecol Oncol 126(2):176–179CrossRefPubMed
13.
Zurück zum Zitat Secord, Hasselblad V AA, Von Gruenigen VE et al (2016) Body mass index and mortality in endometrial cancer: a systematic review and meta-analysis. Gynecol Oncol 140:184–190CrossRefPubMed Secord, Hasselblad V AA, Von Gruenigen VE et al (2016) Body mass index and mortality in endometrial cancer: a systematic review and meta-analysis. Gynecol Oncol 140:184–190CrossRefPubMed
14.
Zurück zum Zitat Soliman PT, Bassett RL, Wilson EB et al (2008) Limited public knowledge of obesity and endometrial cancer risk. Obstet Gynecol 112(4):835–842CrossRefPubMed Soliman PT, Bassett RL, Wilson EB et al (2008) Limited public knowledge of obesity and endometrial cancer risk. Obstet Gynecol 112(4):835–842CrossRefPubMed
16.
Zurück zum Zitat Lake Snell Perry and Associates (2003) Obesity as a public health issue: a look at solutions, results from a national poll Lake Snell Perry and Associates (2003) Obesity as a public health issue: a look at solutions, results from a national poll
18.
Zurück zum Zitat Henretta MS, Copeland AR, Kelley SL et al (2014) Perceptions of obesity and cancer risk in female bariatric surgery candidates: highlighting the need for physician action for unsuspectingly obese and high risk patients. Gynecol Oncol 133(3):73–77CrossRefPubMed Henretta MS, Copeland AR, Kelley SL et al (2014) Perceptions of obesity and cancer risk in female bariatric surgery candidates: highlighting the need for physician action for unsuspectingly obese and high risk patients. Gynecol Oncol 133(3):73–77CrossRefPubMed
Metadaten
Titel
Obesity risk awareness in women with endometrial cancer
verfasst von
Elizabeth V. Connor
Christina A. Raker
Melissa A. Clark
Ashley R. Stuckey
Publikationsdatum
06.02.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 4/2017
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-017-4301-4

Weitere Artikel der Ausgabe 4/2017

Archives of Gynecology and Obstetrics 4/2017 Zur Ausgabe

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

Neue S3-Leitlinie zur unkomplizierten Zystitis: Auf Antibiotika verzichten?

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Gestationsdiabetes: In der zweiten Schwangerschaft folgenreicher als in der ersten

13.05.2024 Gestationsdiabetes Nachrichten

Das Risiko, nach einem Gestationsdiabetes einen Typ-2-Diabetes zu entwickeln, hängt nicht nur von der Zahl, sondern auch von der Reihenfolge der betroffenen Schwangerschaften ab.

Embryotransfer erhöht womöglich Leukämierisiko der Kinder

13.05.2024 Assistierte Reproduktion Nachrichten

Reproduktionsmedizinische Techniken haben theoretisch das Potenzial, den epigenetischen Code zu verändern und somit das Krebsrisiko der Kinder zu erhöhen. Zwischen Embryotransfer und Leukämie scheint sich ein solcher Zusammenhang bestätigt zu haben.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.